UNSPSC 51283211: Fidaxomicin

This classification denotes a macrolide antibiotic with the molecular formula C52H74Cl2O18, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z5N076G8YQ, chemically known as [(2R,3S,4S,5S,6R)-6-[[(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl]oxy-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy]-4-hydroxy-5-methoxy-2-methyloxan-3-yl]3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate but generally known as Fidaxomicin, which bears US NIH Compound Identifier 10034073.

UNSPSC 51283211 Fidaxomicin is a Commodity code tracking pharmaceutical procurement by state and local health agencies. State and local governments purchase this antibiotic through competitive bidding processes, often piggybacking on established pharmaceutical consortiums or cooperative purchasing vehicles to streamline procurement and leverage volume discounts. Recent opportunities show health departments and county health systems acquiring fidaxomicin and related pharmaceuticals through IFB and piggyback contracts to support clinical and public health programs, including emergency preparedness and community health initiatives.

State health departments and county health agencies dominate solicitation activity under this code. Illinois Department of Public Health and Seminole County, Florida have posted recent opportunities. The geographic spread includes Illinois and Florida based on recent postings. Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 for pharmaceutical supplies totaling $2,999,999.11 over the contract life with a 12-month initial term and two one-year renewal options; Seminole County, Florida issued an IFB on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, using an electronic procurement portal and a two-year initial term with one-year renewal option. Neither opportunity showed explicit set-asides or enterprise program requirements.